May 28, 2017
Recommended Topic Related To:


"Methylnaltrexone, which is approved for the treatment of opioid-related constipation, appears to extend survival in people receiving opioids for advanced cancer pain, according to new research.

Increasing evidence indicates that treat"...


Emend Capsules



No specific information is available on the treatment of overdosage.

Drowsiness and headache were reported in one patient who ingested 1440 mg of EMEND (approximately 11 times the maximum recommended single dose).

In the event of overdose, EMEND should be discontinued and general supportive treatment and monitoring should be provided. Because of the antiemetic activity of EMEND, drug-induced emesis may not be effective in cases of EMEND overdosage.

Aprepitant is not removed by hemodialysis.


EMEND is contraindicated in patients:

  • who are hypersensitive to any component of the product. Hypersensitivity reactions including anaphylactic reactions have been reported [see ADVERSE REACTIONS].
  • taking pimozide. Inhibition of CYP3A4 by aprepitant could result in elevated plasma concentrations of this drug which is a CYP3A4 substrate, potentially causing serious or life-threatening reactions, such as QT prolongation, a known adverse reaction of pimozide [see WARNINGS AND PRECAUTIONS].
This monograph has been modified to include the generic and brand name in many instances.

Last reviewed on RxList: 12/26/2015


Emend Capsules - User Reviews

Emend Capsules User Reviews

Now you can gain knowledge and insight about a drug treatment with Patient Discussions.

Here is a collection of user reviews for the medication Emend Capsules sorted by most helpful. Patient Discussions FAQs

Report Problems to the Food and Drug Administration


You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


Get the latest treatment options.